GC-001

GC001溶瘤痘苗病毒

Report date: 2026/04/13 20:02:18

Base Information

Drug NameGC-001
Drug Alias NameGC001GC-001
ClassificationBiologics > Oncolytic virusSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA
Mechanisms of ActionStriatin-interacting protein 1 inhibitors
TargetsStriatin-interacting protein 1
Therapy Area/IndicationsHigh-Grade GliomaSolid tumoursUterine Cervical Neoplasms +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Gongchu Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGONGCHU Biotechnology Co LtdHangzhou Gongchu Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHigh-Grade GliomaSolid tumoursUterine Cervical Neoplasms +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A